Generic selegiline patch tested against brand in healthy volunteers
NCT ID NCT07571824
First seen May 22, 2026 · Last updated May 22, 2026
Summary
This study tests whether a new generic selegiline skin patch works the same as the brand-name EMSAM patch in 92 healthy adults. Researchers will measure how much drug gets into the body and how well the patch sticks to the skin over 24 hours. The goal is to show the generic version is a safe and effective alternative.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novum Pharmaceutical Research Services
RECRUITINGLas Vegas, Nevada, 89121, United States
Conditions
Explore the condition pages connected to this study.